| Date | Title | Description | Source |
| 18.04.2024 | Diamyd Medical announces final outcome in the company’s righ... | Diamyd Medical announces final outcome in the company’s rights issue
Thu, Apr 18, 2024 08:45 CET Rep... | news.cisio... |
| 16.04.2024 | Diamyd Medical announces preliminary outcome in the company’... | Diamyd Medical announces preliminary outcome in the company’s rights issue
Tue, Apr 16, 2024 18:05 C... | news.cisio... |
| 12.04.2024 | Recruitment milestone reached in Diamyd® Phase 3 trial | Recruitment milestone reached in Diamyd® Phase 3 trial
Fri, Apr 12, 2024 09:30 CET Report this conte... | news.cisio... |
| 11.04.2024 | Diamyd Medical led ASSET innovation partnership organizes a ... | Diamyd Medical led ASSET innovation partnership organizes a workshop on the future treatment of Type... | news.cisio... |
| 05.04.2024 | Diamyd Medical's main Shareholders announce their subscripti... | Diamyd Medical's main Shareholders announce their subscription commitments in the ongoing rights iss... | news.cisio... |
| 28.03.2024 | Diamyd Medical publishes prospectus with regards to the righ... | Diamyd Medical publishes prospectus with regards to the rights issue
Thu, Mar 28, 2024 11:30 CET Rep... | news.cisio... |
| 18.03.2024 | The Board of Directors in Diamyd Medical have resolved on a ... | The Board of Directors in Diamyd Medical have resolved on a rights issue of approximately SEK 114 mi... | news.cisio... |
| 29.02.2024 | Diamyd Medical to present new genetic data at the ASIT summi... | Diamyd Medical to present new genetic data at the ASIT summit in Boston, MA
Thu, Feb 29, 2024 13:10 ... | news.cisio... |
| 15.02.2024 | Diamyd Medical receives U.S. FDA Fast Track designation for ... | Diamyd Medical receives U.S. FDA Fast Track designation for Diamyd®
Thu, Feb 15, 2024 09:10 CET Repo... | news.cisio... |
| 14.02.2024 | Publication in Diabetologia highlights AI's potential for Ty... | Publication in Diabetologia highlights AI's potential for Type 1 Diabetes screening
Wed, Feb 14, 202... | news.cisio... |
| 24.01.2024 | In-depth analysis of Diamyd® Phase II trial further supports... | In-depth analysis of Diamyd® Phase II trial further supports value of preserved insulin secretion
We... | news.cisio... |
| 08.01.2024 | Diamyd Medical gains market research findings to guide U.S. ... | Diamyd Medical gains market research findings to guide U.S. commercial strategy
Mon, Jan 08, 2024 08... | news.cisio... |
| 04.01.2024 | Diamyd® precision medicine Phase 3 trial key interim analysi... | Diamyd® precision medicine Phase 3 trial key interim analysis in July
Thu, Jan 04, 2024 09:10 CET Re... | news.cisio... |
| 06.12.2023 | Diamyd Medical's Precision Medicine patent for the preventio... | Diamyd Medical's Precision Medicine patent for the prevention and treatment of autoimmune diabetes g... | news.cisio... |
| 30.11.2023 | Bulletin from Annual General Meeting of Diamyd Medical AB | Bulletin from Annual General Meeting of Diamyd Medical AB
Thu, Nov 30, 2023 16:45 CET Report this co... | news.cisio... |
| 29.11.2023 | Annual Report 2022/2023 | Annual Report 2022/2023
Wed, Nov 29, 2023 15:40 CET Report this content
Diamyd Medical's Annual Repo... | news.cisio... |
| 09.11.2023 | Information about the Annual Report 2022/23 | Information about the Annual Report 2022/23
Thu, Nov 09, 2023 08:28 CET Report this content
Diamyd M... | news.cisio... |
| 07.11.2023 | Diamyd Medical partners with DiaUnion to recruit participant... | Diamyd Medical partners with DiaUnion to recruit participants for Type 1 diabetes prevention trial
T... | news.cisio... |
| 01.11.2023 | Diamyd Medical announces final outcome in the company’s righ... | Diamyd Medical announces final outcome in the company’s rights issue
Wed, Nov 01, 2023 19:00 CET Rep... | news.cisio... |
| 31.10.2023 | Diamyd Medical announces preliminary outcome in the company’... | Diamyd Medical announces preliminary outcome in the company’s rights issue
Tue, Oct 31, 2023 18:30 C... | news.cisio... |
| 26.10.2023 | Follow-up study suggests Diamyd® may offer advantages in del... | Follow-up study suggests Diamyd® may offer advantages in delaying type 1 diabetes onset
Thu, Oct 26,... | news.cisio... |
| 20.10.2023 | Preliminary results from Booster trial with Diamyd® provide ... | Preliminary results from Booster trial with Diamyd® provide additional support for intralymphatic in... | news.cisio... |
| 17.10.2023 | Diamyd Medical announces a webcast presentation on October 2... | Diamyd Medical announces a webcast presentation on October 20 regarding its industry partnership wit... | news.cisio... |
| 16.10.2023 | Diamyd Medical publishes prospectus with regards to the righ... | Diamyd Medical publishes prospectus with regards to the rights issue
Mon, Oct 16, 2023 09:30 CET Rep... | news.cisio... |
| 10.10.2023 | Bulletin from Extra General Meeting of Diamyd Medical AB | Bulletin from Extra General Meeting of Diamyd Medical AB
Tue, Oct 10, 2023 10:45 CET Report this con... | news.cisio... |
| 02.10.2023 | Anders Essen-Möller has been appointed Chairman of the Board... | Anders Essen-Möller has been appointed Chairman of the Board of Diamyd Medical
Mon, Oct 02, 2023 08:... | news.cisio... |
| 05.09.2023 | Registrational Phase III trial in Type 1 Diabetes with Diamy... | Registrational Phase III trial in Type 1 Diabetes with Diamyd® expands to the US
Tue, Sep 05, 2023 1... | news.cisio... |
| 16.08.2023 | Results from Diamyd® Antigen-Specific Immunotherapy Trial in... | Results from Diamyd® Antigen-Specific Immunotherapy Trial in LADA published in scientific journal
We... | news.cisio... |
| 28.06.2023 | Diamyd Medical announces final outcome in the company’s righ... | Diamyd Medical announces final outcome in the company’s rights issue
Wed, Jun 28, 2023 18:30 CET Rep... | news.cisio... |
| 27.06.2023 | Diamyd Medical announces preliminary outcome in the company’... | Diamyd Medical announces preliminary outcome in the company’s rights issue
Tue, Jun 27, 2023 18:15 C... | news.cisio... |
| 26.06.2023 | Bulletin from Extra General Meeting of Diamyd Medical AB | Bulletin from Extra General Meeting of Diamyd Medical AB
Mon, Jun 26, 2023 10:30 CET Report this con... | news.cisio... |
| 19.06.2023 | Diamyd Medical's largest owner fully subscribes for his shar... | Diamyd Medical's largest owner fully subscribes for his share in the ongoing rights issue
Mon, Jun 1... | news.cisio... |
| 13.06.2023 | Diamyd Medical refrains from enforcing the underwriting agre... | Diamyd Medical refrains from enforcing the underwriting agreements in the rights issue and extends t... | news.cisio... |
| 09.06.2023 | Diamyd Medical provides an update regarding the ongoing new ... | Diamyd Medical provides an update regarding the ongoing new share issue
Fri, Jun 09, 2023 16:50 CET ... | news.cisio... |
| 05.06.2023 | Trading in subscription rights in Diamyd Medical's rights is... | Trading in subscription rights in Diamyd Medical's rights issue halted
Mon, Jun 05, 2023 14:30 CET R... | news.cisio... |
| 01.06.2023 | Diamyd Medical provides supplementary information about the ... | Diamyd Medical provides supplementary information about the upcoming Extraordinary General Meeting
T... | news.cisio... |
| 24.05.2023 | Diamyd Medical resolves on a rights issue of shares of appro... | Diamyd Medical resolves on a rights issue of shares of approximately SEK 163 million and convenes an... | news.cisio... |
| 10.05.2023 | Topline results from Remygen® trial in individuals with long... | Topline results from Remygen® trial in individuals with long-term Type 1 Diabetes
Wed, May 10, 2023 ... | news.cisio... |
| 20.04.2023 | Minor timeline revision for Remygen® trial topline results | Minor timeline revision for Remygen® trial topline results
Thu, Apr 20, 2023 13:10 CET Report this c... | news.cisio... |
| 04.04.2023 | Diamyd Medical partners with JDRF to advance the DIAGNODE-3 ... | Diamyd Medical partners with JDRF to advance the DIAGNODE-3 Phase 3 trial in Type 1 Diabetes
Tue, Ap... | news.cisio... |
| 27.03.2023 | Remygen® trial results to be presented in April | Remygen® trial results to be presented in April
Mon, Mar 27, 2023 13:25 CET Report this content
The ... | news.cisio... |
| 10.03.2023 | Diamyd Medical brings Karin Rosén, M.D, PhD, to its Board of... | Diamyd Medical brings Karin Rosén, M.D, PhD, to its Board of Directors
Fri, Mar 10, 2023 07:40 CET R... | news.cisio... |
| 20.02.2023 | Patient recruitment for the pivotal Diamyd® Phase 3 trial is... | Patient recruitment for the pivotal Diamyd® Phase 3 trial is progressing according to plan
Mon, Feb ... | news.cisio... |
| 06.02.2023 | Diamyd Medical receives patent protection in the US and Japa... | Diamyd Medical receives patent protection in the US and Japan for GABA formulation Remygen®
Mon, Feb... | news.cisio... |
| 16.12.2022 | Type 1 Diabetes prevention trial with the antigen-specific i... | Type 1 Diabetes prevention trial with the antigen-specific immunotherapy Diamyd® approved to start
F... | news.cisio... |
| 08.12.2022 | Update: Diamyd Medical’s CEO clarifies comments on the recen... | Update: Diamyd Medical’s CEO clarifies comments on the recent approval by FDA of Provention Bio´s dr... | news.cisio... |
| 06.12.2022 | Diamyd Medical precision medicine patent for prevention and ... | Diamyd Medical precision medicine patent for prevention and treatment of autoimmune diabetes to be g... | news.cisio... |
| 01.12.2022 | Bulletin from Annual General Meeting of Diamyd Medical AB | Bulletin from Annual General Meeting of Diamyd Medical AB
Thu, Dec 01, 2022 17:00 CET Report this co... | news.cisio... |
| 01.12.2022 | Diamyd Medical provides general update ahead of today’s Annu... | Diamyd Medical provides general update ahead of today’s Annual General Meeting
Thu, Dec 01, 2022 12:... | news.cisio... |
| 29.11.2022 | Annual Report 21/22 | Annual Report 21/22
Tue, Nov 29, 2022 16:10 CET Report this content
Diamyd Medical's Annual Report f... | news.cisio... |
| 26.11.2022 | US Partial Clinical Hold on Diamyd® Phase III Trial Lifted b... | US Partial Clinical Hold on Diamyd® Phase III Trial Lifted by the FDA
Sat, Nov 26, 2022 13:20 CET Re... | news.cisio... |
| 18.11.2022 | Diamyd Medical’s CEO comments on the recent approval by FDA ... | Diamyd Medical’s CEO comments on the recent approval by FDA of Provention Bio´s drug candidate Tepli... | news.cisio... |
| 20.09.2022 | Updated results from clinical trial with Diamyd® presented t... | Updated results from clinical trial with Diamyd® presented today at diabetes conference
Tue, Sep 20,... | news.cisio... |
| 05.08.2022 | Five-month results from Diamyd® trial in LADA published in p... | Five-month results from Diamyd® trial in LADA published in peer-reviewed scientific journal
Fri, Aug... | news.cisio... |
| 07.07.2022 | Promising topline results for intralymphatic Diamyd® in pati... | Promising topline results for intralymphatic Diamyd® in patients with LADA
Thu, Jul 07, 2022 15:40 C... | news.cisio... |
| 30.06.2022 | Diamyd Medical joins international consortium in Type 1 Diab... | Diamyd Medical joins international consortium in Type 1 Diabetes
Thu, Jun 30, 2022 13:00 CET Report ... | news.cisio... |
| 06.06.2022 | Analysis supporting treatment with Diamyd® published in peer... | Analysis supporting treatment with Diamyd® published in peer-reviewed scientific journal
Mon, Jun 06... | news.cisio... |
| 30.05.2022 | Immunological analysis of prevention trial with Diamyd® publ... | Immunological analysis of prevention trial with Diamyd® published in peer-reviewed scientific journa... | news.cisio... |
| 19.05.2022 | First patient enrolled in Diamyd Medical's Phase III trial D... | First patient enrolled in Diamyd Medical's Phase III trial DIAGNODE-3
Thu, May 19, 2022 14:15 CET Re... | news.cisio... |
| 09.05.2022 | Diamyd Medical's principal owner transfers half of his holdi... | Diamyd Medical's principal owner transfers half of his holdings in Diamyd Medical to his children
Mo... | news.cisio... |
| 29.04.2022 | Diamyd® meta-analysis is now available as Open Access public... | Diamyd® meta-analysis is now available as Open Access publication
Fri, Apr 29, 2022 10:00 CET Report... | news.cisio... |
| 20.04.2022 | New meta-analysis with Diamyd® published in scientific journ... | New meta-analysis with Diamyd® published in scientific journal
Wed, Apr 20, 2022 11:55 CET Report th... | news.cisio... |
| 13.04.2022 | New clinical trial will evaluate an additional injection (bo... | New clinical trial will evaluate an additional injection (booster) with Diamyd®
Wed, Apr 13, 2022 14... | news.cisio... |
| 30.03.2022 | Quarterly Report II 21/22 | Quarterly Report II 21/22
Wed, Mar 30, 2022 08:15 CET Report this content
September 2021 – February ... | news.cisio... |
| 28.03.2022 | Diabetes prevention project coordinated by Diamyd Medical to... | Diabetes prevention project coordinated by Diamyd Medical to be presented at scientific conference
M... | news.cisio... |
| 15.03.2022 | Diamyd Medical has opened the first clinic for the recruitme... | Diamyd Medical has opened the first clinic for the recruitment of patients for a Phase III trial in ... | news.cisio... |
| 08.02.2022 | Clinical trial in type 1 diabetes with Diamyd Medical's Remy... | Clinical trial in type 1 diabetes with Diamyd Medical's Remygen® is fully recruited
Tue, Feb 08, 202... | news.cisio... |
| 06.02.2022 | Diamyd Medical proceeds with initiation of Type 1 Diabetes P... | Diamyd Medical proceeds with initiation of Type 1 Diabetes Phase III trial in Europe
Sun, Feb 06, 20... | news.cisio... |
| 26.01.2022 | Quarterly Report I 21/22 | September 2021 - November 2021, Diamyd Medical AB (publ), Fiscal year 2021/2022
Developing Precision... | marketscre... |
| 18.01.2022 | Diamyd Medical patent for intralymphatic injection of GAD in... | Diamyd Medical patent for intralymphatic injection of GAD in autoimmune diabetes to be granted in Ch... | news.cisio... |
| 23.12.2021 | Australia grants as the first region Diamyd Medical a broade... | Australia grants as the first region Diamyd Medical a broadening of a patent for intralymphatic inje... | news.cisio... |
| 21.12.2021 | Annual Report 20/21 | Annual Report 20/21 Tue, Dec 21, 2021 17:15 CET
Diamyd Medical's Annual Report for the financial yea... | news.cisio... |
| 07.12.2021 | Interim report for Diamyd® directly into the lymph node for ... | Interim report for Diamyd® directly into the lymph node for patients with LADA Tue, Dec 07, 2021 11:... | news.cisio... |
| 02.12.2021 | Bulletin from Annual General Meeting of Diamyd Medical AB | Bulletin from Annual General Meeting of Diamyd Medical AB Thu, Dec 02, 2021 16:45 CET
The Annual Gen... | news.cisio... |
| 30.11.2021 | Diamyd Medical pauses start of Phase III trial – Update | Diamyd Medical pauses start of Phase III trial – Update Tue, Nov 30, 2021 22:15 CET
The potential co... | news.cisio... |
| 30.11.2021 | Diamyd Medical pauses start of Phase III trial | Diamyd Medical pauses start of Phase III trial Tue, Nov 30, 2021 13:45 CET
Diamyd Medical has today ... | news.cisio... |
| 18.10.2021 | Diamyd Medical to initiate its Type 1 diabetes Phase III tri... | Diamyd Medical to initiate its Type 1 diabetes Phase III trial in Europe as discussions continue wit... | news.cisio... |
| 13.10.2021 | Diamyd Medical : Year-End Report 20/21 | September 2020 - August 2021, Diamyd Medical AB (publ), Fiscal year 2020/2021
Developing Precision M... | marketscre... |
| 13.10.2021 | Diamyd Medical : October 13, 2021 Year-End Report 20/21 | YEAR-END REPORT
September 2020 - August 2021
Diamyd Medical AB (publ), Fiscal year 2020/2021
Develop... | marketscre... |
| 12.10.2021 | Clinical results with Diamyd Medical’s study drug Remygen® p... | Clinical results with Diamyd Medical’s study drug Remygen® published in scientific journal Tue, Oct ... | news.cisio... |
| 12.10.2021 | Diamyd Medical : Clinical results with Diamyd Medical's stud... | The clinical results from the dose-escalation part of the investigator-initiated clinical Phase I/II... | marketscre... |
| 11.10.2021 | The diabetes vaccine Diamyd® to be featured in two oral pres... | The diabetes vaccine Diamyd® to be featured in two oral presentations at the International Diabetes ... | news.cisio... |
| 11.10.2021 | Diamyd Medical : The diabetes vaccine Diamyd® to be featured... | Two abstracts, highlighting clinical results that showed improved glycemic control following treatme... | marketscre... |
| 23.09.2021 | Diamyd Medical and partners are awarded SEK 40 million in VI... | Diamyd Medical and partners are awarded SEK 40 million in VINNOVA funding for the prevention of auto... | news.cisio... |
| 23.09.2021 | A new analysis that supports the effect of the diabetes vacc... | A new analysis that supports the effect of the diabetes vaccine Diamyd® will be presented at a scien... | news.cisio... |
| 21.09.2021 | Diamyd Medical : receives first regulatory approval to start... | Diamyd Medical announces today that The Swedish Medical Products Agency has given approval for the s... | marketscre... |
| 21.09.2021 | Diamyd Medical receives first regulatory approval to start t... | Diamyd Medical receives first regulatory approval to start the Phase III trial DIAGNODE-3 with the d... | news.cisio... |
| 17.09.2021 | FDA pauses start of DIAGNODE-3 in the US pending clarificati... | FDA pauses start of DIAGNODE-3 in the US pending clarification on study drug Fri, Sep 17, 2021 12:20... | news.cisio... |
| 15.09.2021 | Diamyd Medical acquires property with manufacturing facility... | Diamyd Medical acquires property with manufacturing facility in Umeå, Sweden Wed, Sep 15, 2021 14:10... | news.cisio... |
| 10.09.2021 | Diamyd Medical : carries out a directed share issue and rais... | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ... | marketscre... |
| 10.09.2021 | Diamyd Medical changes date for publication of year-end repo... | Diamyd Medical changes date for publication of year-end report Fri, Sep 10, 2021 15:30 CET
Diamyd Me... | news.cisio... |
| 09.09.2021 | Diamyd Medical AB intends to carry out a directed share issu... | Diamyd Medical AB intends to carry out a directed share issue of B-shares Thu, Sep 09, 2021 19:35 CE... | news.cisio... |
| 09.09.2021 | Diamyd Medical : intends to carry out a directed share issue... | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, ... | marketscre... |
| 09.09.2021 | Diamyd Medical carries out a directed share issue and raises... | Diamyd Medical carries out a directed share issue and raises proceeds of SEK 150 million Thu, Sep 09... | news.cisio... |
| 31.08.2021 | Diamyd Medical’s rhGAD65 manufacturing facility on track for... | Diamyd Medical’s rhGAD65 manufacturing facility on track for Diamyd® vaccine production Tue, Aug 31,... | news.cisio... |
| 26.08.2021 | Additional analyses show robust treatment effect of the ther... | Additional analyses show robust treatment effect of the therapeutic vaccine Diamyd® Thu, Aug 26, 202... | news.cisio... |
| 26.08.2021 | Diamyd Medical : A dditional analyses show robust treatment ... | Diamyd Medical has, as part of interactions with regulatory agencies, conducted two new analyses on ... | marketscre... |
| 26.08.2021 | Diamyd Medical : Additional analyses show robust treatment e... | Diamyd Medical has, as part of interactions with regulatory agencies, conducted two new analyses on ... | marketscre... |
| 18.08.2021 | Diamyd Medical strengthens presence at scientific conference... | Diamyd Medical strengthens presence at scientific conferences Wed, Aug 18, 2021 08:45 CET
Diamyd Med... | news.cisio... |
| 09.08.2021 | Diamyd Medical : secures precision medicine patent for preve... | The European Patent Office has informed Diamyd Medical that the Company's patent application regardi... | marketscre... |
